PELL Bio-Med Technology Co (TPE:6949) Tariff Resilience Score: 0/10 (As of Jul. 11, 2026)


TPE:6949 PELL Bio-Med Technology Co Ltd TPE:6949
13 GF Score
Price NT$925.00
! 5 Warning Signs
View Full Analysis

What is PELL Bio-Med Technology Co Tariff Resilience Score?

PELL Bio-Med Technology Co has the Tariff Resilience Score of 0, which implies that the company might have .

PELL Bio-Med Technology Co has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes PELL Bio-Med Technology Co might have .


PELL Bio-Med Technology Co  (TPE:6949) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

PELL Bio-Med Technology Co Tariff Resilience Score Related Terms

TPE:6949
13GF Score
PELL Bio-Med Technology Co Ltd TPE:6949
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PELL Bio-Med Technology Co Business Description

Address No. 87, Xinhu 2nd Road, 4th Floor, Neihu District, Taipei, TWN
PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell). The company's segments includes Cell products, Consulting services, and Others.
13GF Score

Get the complete analysis for TPE:6949

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$925.00
Price